Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Overview of attention for article published in The Lancet, January 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 80 news outlets
blogs: 9 blogs
policy: 2 policy sources
twitter: 217 X users
patent: 1 patent

facebook: 10 Facebook pages
wikipedia: 2 Wikipedia pages
reddit: 6 Redditors
f1000: 1 research highlight platform
video: 1 YouTube creator

Citations

dimensions_citation: 670 Dimensions

Readers on

mendeley: 881 Mendeley
citeulike: 1 CiteULike

Summary News Blogs Policy documents X Patents Facebook Wikipedia Reddit Research highlights YouTube Dimensions citations

So far, Dimensions has found 670 publications that cite this research output.

670

The most recent citing publications are shown below. View all 670 publications that cite this research output on Dimensions.

Medical Use of Cannabinoids and Psychedelic Compounds

Book chapter (September 2024)

Proceedings of the 2022 “Lifestyle Intervention for Epilepsy (LIFE)” symposium hosted by Cleveland Clinic

Article in Epilepsia Open (August 2024)

Cannabinoid receptor 2 agonist AM1241 alleviates epileptic seizures and epilepsy-associated depression via inhibiting neuroinflammation in a pilocarpine-induced chronic epilepsy mouse model

Article in Molecular and Cellular Neuroscience (August 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.